Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant health concern worldwide. This article provides an updated approach to the diagnosis and treatment of enteric fever, incorporating recent advancements in medical science.
Early diagnosis of enteric fever is crucial for effective management. The gold standard for diagnosis remains blood culture, which has a sensitivity of 40-60%. However, this method is limited by the need for sophisticated laboratories and slow turnaround times. Recent advancements include the introduction of rapid diagnostic tests (RDTs) such as the Typhidot and Tubex TF, which are based on detecting IgM antibodies against the bacteria. These RDTs have shown promising results in endemic regions, with higher sensitivity and specificity compared to traditional methods.
Treatment of enteric fever has been complicated by the emergence of multidrug-resistant strains. The World Health Organization currently recommends ceftriaxone or cefixime for uncomplicated cases, and ciprofloxacin for complicated cases. However, due to increasing resistance, azithromycin has emerged as a viable alternative. Adjunctive therapies, such as probiotics and zinc supplementation, are also being explored to reduce the duration and severity of illness.
Prevention strategies are key in controlling the spread of enteric fever. Vaccination remains the most effective measure, with the Vi polysaccharide and Ty21a vaccines showing good efficacy. In addition, improving water quality, sanitation, and hygiene practices are crucial in endemic regions to reduce transmission.
Enteric fever continues to present significant challenges in diagnosis and treatment. Incorporating rapid diagnostic tests into clinical practice and exploring alternative treatment options, such as azithromycin, may improve patient outcomes. A multifaceted approach encompassing prevention strategies, including vaccination and improved sanitation, is essential to control the spread of this disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation